Shareholder Protection Insurance And Cross-Option Agreements: The IHT Angles Most Firms Miss
Shareholder Protection Insurance and Cross-Option Agreements: The IHT Angles Most Firms Miss
A shareholder protection arrangement that uses a binding buy and sell agreement, rather than a cross-option agreement, can destroy Business Relief entirely on the deceased shareholder's shares, converting what should be a tax-free transfer into one taxed at up to 40%. For the 2026/27 tax year, this distinction, hinging on a single word in the underlying legal document, is one of the most consequential and most frequently overlooked details in private company succession planning.
I've reviewed a fair number of shareholder protection arrangements over the years that were set up correctly from an insurance perspective, adequate cover, sensible premium levels, policies actually in force, but structured in a way that quietly undermines the Inheritance Tax position the arrangement was partly meant to protect. The insurance broker gets the sum assured right. The corporate solicitor gets the company law mechanics right. What frequently falls through the gap is whether the underlying legal agreement itself preserves Business Relief, and that gap is exactly where I want to focus.
The core distinction: options versus obligations
Under section 113 of the Inheritance Tax Act 1984, business property that is subject to a binding contract for sale at the time of a transfer is not relevant business property, and Business Relief is denied entirely. HMRC's Statement of Practice 12/80 sets out precisely how this applies to shareholder arrangements, and the internal guidance in HMRC's Inheritance Tax Manual at IHTM25292 on contracts for sale involving shareholdings and partnership interests confirms the mechanics that determine which side of the line a given arrangement falls on.
A "buy and sell" agreement, in HMRC's own terminology, exists where the arrangement requires the deceased shareholder's shares to pass to their personal representatives, requires those personal representatives to sell the shares to the surviving shareholders, and obliges the surviving shareholders to buy them. Where all three elements are present, a binding contract for sale exists at the point of death, and Business Relief is lost on those shares entirely, not reduced, lost. HMRC's manual is explicit that these requirements are rarely satisfied by accident, but they are satisfied more often than practitioners expect when a shareholders' agreement has been drafted, or more commonly adapted from an old template, without this specific point in mind.
A cross-option agreement, sometimes called a double option agreement, avoids this outcome by design. Instead of a mutual obligation, it grants the deceased's estate an option to require the surviving shareholders to buy the shares, and separately grants the surviving shareholders an option to require the estate to sell. Because neither side is obliged to complete a transaction, merely entitled to insist on one, HMRC's own guidance confirms that this structure does not constitute a contract for sale within section 113, and Business Relief continues to be available on the shares in the normal way. The practical difference between the two structures, at the moment of drafting, can be as narrow as replacing "the surviving shareholders shall purchase" with "the surviving shareholders may be required to purchase at the estate's election," but the Inheritance Tax consequences of getting that wording wrong are substantial.
Designed by Pro Tax Accountant, this interactive explainer reveals how an inadvertent "buy and sell" clause in your shareholder agreement can breach Section 113 IHTA 1984, forfeiting Business Relief and triggering up to a 40% Inheritance Tax charge on your company shares. It highlights the vital legal distinction between binding obligations and double-option structures, whilst walking through essential policy trusts, premium gifting exemptions, and the April 2026 £2.5m relief threshold. Simply adjust the interactive valuation slider to model your potential tax liability under both arrangements, and work through the six-point succession audit to pinpoint critical vulnerabilities in your existing company documents.
What this actually costs, in real terms
Following the changes to Business Relief taking effect from 6 April 2026, discussed in more detail below, the value of getting this right has increased rather than diminished. A shareholding worth £3 million that qualifies fully for Business Relief under the reformed rules faces a materially lower Inheritance Tax charge than the same shareholding stripped of relief entirely by a badly drafted buy and sell agreement, where the full 40% rate applies to the whole value above the deceased's available nil-rate band. For a business owner who has spent a career building value in a private company, the difference between a properly structured cross-option arrangement and an inadvertent buy and sell agreement is not a technical footnote, it's frequently the difference between the business passing intact and a forced sale to fund the tax.
The Business Relief reform landscape from 6 April 2026
This is a live and moving area, and worth stating precisely rather than relying on outdated figures still circulating from earlier in the reform process. At Autumn Budget 2024, the government announced that from 6 April 2026, the current unlimited 100% rate of relief for qualifying business and agricultural property would be capped. The original proposal set that cap at £1 million combined for Business Relief and Agricultural Relief together, with 50% relief on anything above it. Following representations from the farming and business community, the government announced on 23 December 2025 that this allowance would be increased, and HMRC's own confirmation states that the threshold will rise to £2.5 million from April 2026, up from the originally proposed £1 million.
This means that from 6 April 2026, the first £2.5 million of combined qualifying business and agricultural property in an estate continues to attract 100% relief, with 50% relief applying to any value above that figure, producing an effective Inheritance Tax rate of up to 20% on the excess rather than the standard 40%. Crucially for shareholder protection planning specifically, this £2.5 million allowance is transferable between spouses and civil partners in the same way as the nil-rate band, meaning a married couple can shelter up to £5 million of combined qualifying business and agricultural property between them before the reduced 50% rate begins to bite. Separately, the rate of Business Relief available on shares admitted to trading on a recognised stock exchange but not formally listed, which captures AIM-quoted shares, is being reduced from 100% to 50% in all circumstances, regardless of the value involved.
For a majority of owner-managed private companies, particularly smaller and mid-sized businesses, this £2.5 million allowance means the reforms will have no practical effect at all. But for shareholders in higher-value private companies, the interaction between the reformed relief and a shareholder protection arrangement that inadvertently forfeits Business Relief altogether becomes considerably more expensive than it would have been under the pre-reform, uncapped 100% rate, since a badly drafted agreement now risks losing relief on a shareholding that could otherwise have benefited from the full £2.5 million allowance.
The policy structure question: whose life, whose trust
Beyond the cross-option versus buy and sell distinction, a second area I see handled inconsistently is how the life insurance policies funding the arrangement are actually structured, and this matters because the policy structure has its own, separate Inheritance Tax implications running alongside the Business Relief question.
The standard approach for shareholder protection is "own life in trust": each shareholder takes out a policy on their own life, for a sum assured broadly matching the current value of their shareholding, and writes it in trust for the benefit of the other shareholders. On that shareholder's death, the policy proceeds pass directly to the trust and from there to the surviving shareholders, entirely outside the deceased's estate, providing the cash needed to exercise the cross-option and buy the shares without the proceeds themselves ever forming part of the deceased's estate for Inheritance Tax purposes.
Where this goes wrong in practice is usually one of two ways. First, policies written on the wrong life, for example a company taking out and owning the policy itself rather than the individual shareholder, which changes the tax and company law analysis considerably and can create unintended distribution or valuation issues on the company's own shares. Second, and more commonly, policies that were correctly written in trust at outset but where the trust itself was never properly aligned with a subsequent change in shareholding, a new shareholder joining, an existing one leaving, or shareholdings being rebalanced, leaving the trust benefiting the wrong people relative to the current cross-option agreement. I'd treat any shareholder protection arrangement more than a few years old, and certainly any that hasn't been reviewed since the shareholder base last changed, as due for a proper check against both the trust wording and the current shareholdings, rather than assuming the original structure still lines up.
Premiums and the gifting question
There's a further, quieter point that gets missed even by advisers who've got the trust structure right: where one shareholder pays premiums on a policy written in trust for the benefit of others, those premium payments are themselves transfers of value for Inheritance Tax purposes, since the paying shareholder is funding a benefit that will flow to someone else. In practice, this is rarely a problem, because premiums on a shareholder protection policy are typically modest relative to the payer's income and can usually be sheltered by the £3,000 annual exemption, or more robustly, by the normal expenditure out of income exemption under section 21 of the Inheritance Tax Act 1984, provided the payments form a regular pattern funded from income and don't compromise the payer's standard of living.
The point worth flagging to clients explicitly, though, is that this shelter isn't automatic. If premiums are substantial relative to the shareholder's income, or if the pattern of payment is irregular, the transfer of value on each premium technically needs its own exemption or falls to be treated as a potentially exempt transfer in its own right. This is rarely the deciding factor in whether an arrangement works overall, but it's exactly the kind of secondary detail that a firm focused purely on the insurance and company law mechanics can overlook entirely.
Company-owned policies: a different and messier picture
Some businesses structure shareholder protection through company-owned policies rather than own-life-in-trust arrangements, where the company itself takes out and pays for insurance on each shareholder's life, with proceeds used by the company to buy back the deceased's shares directly. This avoids some of the trust administration involved in own-life arrangements, but it introduces a different set of complications that firms focused only on the insurance side sometimes underweight.
A company buying back its own shares from a deceased shareholder's estate needs to navigate the company law requirements for a purchase of own shares, including distributable reserves tests, and the tax treatment of the payment to the estate, which can be treated as an income distribution rather than a capital transaction unless specific conditions under the company purchase of own shares rules are satisfied.
Getting this wrong doesn't generally affect whether Business Relief applies to the shares themselves, that still turns on the cross-option versus buy and sell distinction covered above, but it can create an unexpected Income Tax charge on the estate or the departing shareholder's personal representatives that undermines much of the planning's original purpose. Where a company-owned structure is being used, I'd want the company's professional advisers confirming the buyback mechanics are sound well before any claim is actually triggered, not discovering the gap at the point a payment needs to be made.
This interactive explainer walks UK business owners and advisers through the often-overlooked Inheritance Tax risks in shareholder protection arrangements, focusing on the critical difference between a binding buy-and-sell agreement and a properly drafted cross-option agreement. It shows how the wrong wording can wipe out Business Relief entirely, explains the £2.5 million (and transferable £5 million) relief rules that applied from 6 April 2026, and covers policy structures, premiums and company-owned arrangements. Simply click the tabs at the top to explore each topic, use the built-in calculator to illustrate potential IHT differences, and work through the review checklist to check your own arrangements. The whole widget is designed to be clear, practical and ready to use on a Wix page.
What a proper review actually checks
Given how much turns on relatively narrow points of drafting, a periodic review of an existing shareholder protection arrangement is worth treating as a genuine exercise rather than a box-ticking confirmation that policies remain in force. The review should confirm, specifically, that the underlying legal agreement uses option language throughout, granting rights rather than imposing obligations, since even a well-drafted cross-option agreement can be undermined by a single clause elsewhere in the same document, or in the company's articles, that inadvertently creates a binding obligation.
It should confirm the life policies are written on the correct lives, held in trust where that structure is being used, and that the trust's beneficiaries still match the current shareholder base rather than an earlier one. It should check the sums assured against current share valuations, since a policy set up years ago at an outdated valuation may leave a meaningful funding shortfall at the point it's actually needed. And where the underlying business now sits close to, or above, the £2.5 million combined Business Relief and Agricultural Relief allowance taking effect from 6 April 2026, it's worth modelling what the reformed relief actually means for the shareholding specifically, rather than assuming the pre-reform position still holds.
Scotland and Wales
Business Relief, the section 113 binding contract rules, and the Inheritance Tax treatment of life policies held in trust are all governed by UK-wide legislation and HMRC guidance, with no separate Scottish or Welsh regime. There is, however, a genuine practical difference worth flagging for Scottish clients specifically: shareholders' agreements and cross-option arrangements involving Scottish private companies are drafted against Scots law, which differs from English law in some respects relevant to trusts and contractual obligations, even though the underlying Inheritance Tax analysis under UK tax legislation is identical. A cross-option agreement that works cleanly under English contract law principles needs proper adaptation by a Scots-qualified solicitor to ensure the same option-not-obligation structure is achieved under Scottish contract law, rather than simply having an English-style agreement applied without adjustment. Wales operates under the same legal system as England for these purposes, so no equivalent adaptation is needed there.
FAQs
What's the difference between a cross-option agreement and a buy and sell agreement?
A cross-option agreement grants each side an option, allowing the estate to require a purchase and the surviving shareholders to require a sale, without either side being obliged to complete unless the option is exercised. A buy and sell agreement creates a mutual binding obligation to sell and to buy, which HMRC treats as a binding contract for sale, disqualifying the shares from Business Relief entirely.
Why does this distinction matter for Inheritance Tax?
Under section 113 of the Inheritance Tax Act 1984, business property subject to a binding contract for sale at the time of transfer is not relevant business property and cannot qualify for Business Relief. A cross-option structure avoids creating that binding contract, preserving relief, while a buy and sell agreement creates exactly the obligation that denies it.
How much has changed with the Business Relief reforms from April 2026?
From 6 April 2026, 100% relief is capped at a combined £2.5 million of qualifying business and agricultural property, with 50% relief applying above that figure. This allowance is transferable between spouses and civil partners, allowing a couple to shelter up to £5 million between them.
Does the £2.5 million allowance affect whether I need a cross-option agreement?
No, the two issues are separate. The cross-option structure determines whether Business Relief is available at all on the shares in question, while the £2.5 million allowance determines how much of the relievable value attracts the full 100% rate versus the reduced 50% rate. A badly drafted buy and sell agreement can deny relief entirely regardless of the value involved.
Should the policy be owned by the company or by the individual shareholder?
Both structures are used in practice, but they carry different considerations. Own-life-in-trust policies, where each shareholder insures their own life for the benefit of the others, generally keep the proceeds outside the deceased's estate cleanly. Company-owned policies avoid some trust administration but introduce company law and potential Income Tax complications around the share buyback itself.
Do I need to pay tax on the premiums for a shareholder protection policy written in trust?
The premiums are technically transfers of value if paid for the benefit of other shareholders, but they can usually be covered by the £3,000 annual exemption or the normal expenditure out of income exemption, provided the payments are modest relative to income and form a regular pattern.
What happens if our shareholders' agreement was drafted years ago and the shareholders have changed since?
This is one of the most common gaps in practice. If the trust beneficiaries or the cross-option terms haven't been updated to reflect new or departing shareholders, the arrangement may no longer protect the people it's intended to, even if the original document was correctly structured when first signed.
Can HMRC challenge a cross-option agreement even if it's drafted correctly?
HMRC's manual guidance confirms that properly drafted option-based arrangements do not constitute a contract for sale under section 113, but the wording throughout the entire agreement, and any related company articles, needs to consistently reflect an option structure rather than an obligation. A single inconsistent clause elsewhere in the same set of documents can undermine an otherwise well-drafted arrangement.
Does this apply to partnerships as well as companies?
Yes, the same section 113 analysis and the same distinction between binding buy and sell agreements and option-based structures applies to partnership interests and Business Relief on partnership shares, not just to shares in a limited company.
How often should a shareholder protection arrangement be reviewed?
There's no fixed statutory requirement, but a review is sensible whenever the shareholder base changes, whenever share valuations move significantly, and at minimum every few years even without a specific trigger, given how the Business Relief reforms taking effect from April 2026 change the value of getting the underlying structure right.
About the Author:
Adil Akhtar, ACMA, CGMA, FCMA (membership ID is 990250923) serves as CEO and Chief Accountant at Pro Tax Accountant, bringing over 18 years of expertise in tackling intricate tax issues. As a respected tax blog writer, Adil has spent more than eighteen years delivering clear, practical advice to UK taxpayers. He also leads Advantax Accountants (registered with Companies House), combining technical expertise with a passion for simplifying complex financial concepts, establishing himself as a trusted voice in tax education.
Email: adilacma@icloud.com
Disclaimer: This article sets out the general position under UK tax law for the 2026/27 tax year. The information has been checked against HMRC guidance and other official sources at the date shown above, and is reviewed when the rules change. Tax legislation is complex and outcomes depend on your individual circumstances, so this article is provided for general information and does not constitute advice on which you should act. Any figures or worked examples are illustrative. Before making any decision, obtain advice specific to your situation from a qualified professional. Pro Tax Accountant accepts no liability for loss arising from reliance on this article alone.
.png)